Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 18,156
- Companies
- 1,062
- Drugs tracked
- 3,385
Quick answer
NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Clemizole HCl
Harmony Biosciences Holdings
Lennox Gastaut Syndrome
1 trial -
Clemizole HCl
Harmony Biosciences Holdings
Dravet Syndrome
1 trial -
HBS-101, White, round, plain, biconvex film-coated tablet. Matching 4.45 mg tablet is 3.7 mm in diameter., White, round, plain, biconvex film-coated tablet. matching 17.8 mg tablet is 7.5 mm in diameter., WAKIX, HBS-101, WAKIX
Harmony Biosciences Holdings
Prader-Willi syndrome
1 trial -
HBS-301 tablet
Harmony Biosciences Holdings
Idiopathic Hypersomnia
1 trial -
Open-label pitolisant
Harmony Biosciences Holdings
Idiopathic Hypersomnia
1 trial -
Pitolisant
Harmony Biosciences Holdings
Idiopathic Hypersomnia
1 trial -
Pitolisant
Harmony Biosciences Holdings
Prader-Willi Syndrome
1 trial -
Pitolisant tablet
Harmony Biosciences Holdings
Prader-Willi Syndrome
1 trial -
ZYN002 Transdermal Gel Cannabidiol (CBD)
Harmony Biosciences Holdings
Fragile X Syndrome (FXS)
1 trial -
ZYN002 Transdermal Gel Cannabidiol (CBD), ZYN002 Placebo Transdermal Gel
Harmony Biosciences Holdings
Fragile X syndrome (FXS)
1 trial -
OVX836 480µg
Harmony Biosciences Holdings
Influenza
1 trial -
OVX836 shot
Harmony Biosciences Holdings
Vaccine-Preventable Diseases
1 trial -
Pitolisant Oral Tablet
Harmony Biosciences Holdings
Myotonic Dystrophy 1
1 trial -
Pitolisant oral tablets
Harmony Biosciences Holdings
Prader-Willi Syndrome
1 trial -
ZYN002
Harmony Biosciences Holdings
22Q11.2 Deletion Syndrome
1 trial -
HBS-201
Harmony Biosciences Holdings
Narcolepsy
1 trial -
MV-LASV
Harmony Biosciences Holdings
Lassa Virus Infection
1 trial -
Part 1
Harmony Biosciences Holdings
Drug Interaction
1 trial -
Pitolisant
Harmony Biosciences Holdings
Restless Legs Syndrome
1 trial -
Complex with Biotin 5,000 mcg, Collagen, Keratin and Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial -
Complex with Biotin, Collagen, Keratin, Hyaluronic Acid.
Harmony Biosciences Holdings
Hair Thinning
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources